Skip to main content

Advertisement

Table 1 Viability percentage of MDA-MB-231 at 48 h treated with bromelain and cisplatin combinations

From: Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro

Combination no. Combination dosage (µM) % viability ± SD
Bromelain dosage (IC value) Cisplatin dosage (IC value)
Combination 1 2.0 µM (IC40) 1.5 µM (IC10) 50.24% ± 1.67
Combination 2 0.9 µM (IC30) 4.0 µM (IC20) 70.26% ± 2.66
Combination 3 0.5 µM (IC20) 5.9 µM (IC30) 61.30% ± 2.43
Combination 4 0.24 µM (IC10) 9.5 µM (IC40) 56.95% ± 3.61
  1. Cytotoxicity was determined using the MTT cell viability assay. The results for MTT assay are expressed as mean ± SD of three separate experiments